Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-04-30 Purchase | 2020-05-04 12:28 pm | NeuBase Therapeutics Inc. | NBSE | Backenroth Samuel CFO, Treasurer & Secretary | 1,000 | $6 | $6,000 | 11,630 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-31 Exercise | 2023-04-18 4:36 pm | N/A N/A | Vascular Biogenics Ltd. | VBLT | Backenroth Samuel Chief Financial Officer | 525,000 | $0 | 700,000 (Direct) | View |
Ownership | 2023-01-03 9:04 pm | N/A N/A | Vascular Biogenics Ltd. | VBLT | Backenroth Samuel Chief Financial Officer | 0 | $0 | 1,139,843 (Direct) | View |
| 2020-12-29 Option Award | 2020-12-30 5:01 pm | N/A 2030-12-29 | NeuBase Therapeutics Inc. | NBSE | Backenroth Samuel CFO, Treasurer & Secretary | 41,915 | $0 | 41,915 (Direct) | View |
| 2019-07-12 Other | 2019-07-16 8:32 pm | N/A N/A | NeuBase Therapeutics Inc. | NBSE | Backenroth Samuel CFO, Treasurer & Secretary | 3,000 | $0 | 772,923 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 8:32 pm | N/A 2029-07-12 | NeuBase Therapeutics Inc. | NBSE | Backenroth Samuel CFO, Treasurer & Secretary | 772,923 | $0 | 772,923 (Direct) | View |